Sun Pharma Share Price
₹1607.10
+5.10
(+0.32%)
as on
Sun Pharma Stock Performance
as on September 16, 2025 at 2:58 pm IST
Day's Low
Day's High
₹1,600₹1,610
0.44%
Downside
0.18%
Upside
52 Week's Low
52 Week's High
₹1,553.05₹1,960.353.36%
Downside
21.98%
Upside
Sun Pharma share price movements today
- Previous Close
- ₹1,602.00
- Open
- ₹1,607.20
- Volume
- 10.48L
- Upper Circuit
- ₹1,762.20
- Lower Circuit
- ₹1,441.80
- Day's Low - High
- ₹1,600 - ₹1,610
- 52 Week Low - High
- ₹1,553.05 - ₹1,960.35
Sun Pharma Historical Returns
- 1 Month Return
- -1.88 %
- 3 Month Return
- -4.94 %
- 1 Year Return
- -14.01 %
- 3 Year Return
- + 84.55 %
- 5 Year Return
- + 208.97 %
Sun Pharma Fundamentals
as on September 16, 2025 at 2:58 pm IST
Market Cap
₹3,84,373.46 Cr
Return on Equity (ROE)
17.83
PE Ratio (TTM)
37
Return on capital employed (ROCE)
16.29
Beta (LTM)
0.63
P/B Ratio
17.11
Dividend Yield
0.92
PEG Ratio
0Quarterly Earnings Growth YOY
-19.8
EPS (TTM)
45.76
Sector
Pharmaceuticals
Book Value
301
Technical Analysis
Bearish
View Technical Analysis
Sun Pharmaceutical Industries Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Sun Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 3,84,373.46 | 41.79% | 0.52 | 10,980 | 52,578 | |
| HOLD | 1,60,794.32 | 17.34% | 0.50 | 2,191 | 9,360 | |
| BUY | 1,19,520.02 | 29.69% | 0.66 | 1,911 | 11,516 | |
| BUY | 47,896.72 | -3.67% | 0.78 | 1,429 | 15,261 | |
| HOLD | 33,234.67 | 2.17% | 0.53 | 698 | 5,616 |
Analyst Recommendation on Sun Pharma Stock
Based on 38 analysts
81.58%
Buy
7.89%
Hold
10.53%
Sell
Based on 38 analysts, 81.58% of analysts recommend a 'BUY' rating for Sun Pharma. Average target price of ₹1930.16
Source: S&P Global Market Intelligence
Sun Pharma Share Price Target
Get share price movements and forecasts by analysts on Sun Pharma.
What analysts predicted
20.48%UPSIDE
Target Price
₹1930.16
Current Price
₹1607.1
Analyzed by
38 Analysts
High
₹2450
Target
₹1930.16
Low
₹1525
Sun Pharma target price ₹1930.16, a slight upside of 20.48% compared to current price of ₹1607.1. According to 38 analysts rating.
Source: S&P Global Market Intelligence
Sun Pharma Stock's Interest Amongst Investors
Investment in Sun Pharmaceutical Industries Ltd Shares on INDmoney has dropped by -8.32% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Sun Pharmaceutical Industries Ltd Stock has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Sun Pharmaceutical Industries Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Sun Pharmaceutical Industries Ltd Annual Profit & Loss
Figures in Rupees Crores
Sun Pharmaceutical Industries Ltd Cash Flow
Figures in Rupees Crores
Sun Pharma Stock Shareholding Pattern
Numbers in percentages
Mutual Funds that own Sun Pharma Stock
Check out the Mutual Funds with significant holdings in Sun Pharma.
Funds | Holdings | Shares Held | |
|---|---|---|---|
 ICICI Prudential Value Fund Direct Plan Growth | 4.47% | 15082075 | |
ICICI Prudential Equity & Debt Fund Direct Plan Growth | 4.33% | 12270395 | |
ICICI Prudential Large Cap Fund Direct Plan Growth | 2.57% | 11570567 | |
ICICI Prudential India Opportunities Fund Direct Growth | 5.07% | 9507270 | |
 HDFC Balanced Advantage Fund Direct Plan Growth Option | 1.07% | 6784634 |
Sun Pharma Earnings and Dividends
View detailed summary of the earnings and dividend history of Sun Pharma.
Sun Pharmaceutical Industries Ltd Earnings Results
Sun Pharmaceutical Industries Ltd’s net profit fell -19.64% since last year same period to ₹2,278.63Cr in the Q1 2025-2026. On a quarterly growth basis, Sun Pharmaceutical Industries Ltd has generated 5.99% jump in its net profits since last 3-months.
Read More about Earnings ResultsSun Pharmaceutical Industries Ltd Dividends May,2025
In the quarter ending March 2025, Sun Pharmaceutical Industries Ltd has declared dividend of ₹5.50 per share on 22 May 2025 - translating a dividend yield of 1.30%.
Read More about Dividends
Indices Featuring Sun Pharma Stock
Check stock indices that include Sun Pharma.
Insights on Sun Pharmaceutical Industries Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 13.57K Cr → 14.31K Cr (in ₹), with an average increase of 5.2% per quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 12.21% to 12.63% in Jun 2025 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 2.14K Cr → 2.27K Cr (in ₹), with an average increase of 5.7% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 10.5% return, outperforming this stock by 24.6%
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 138.8% return, outperforming this stock by 54.3%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 54.48% of holdings in Jun 2025 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 8.87% to 8.77% in Jun 2025 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 17.96% to 17.26% in Jun 2025 quarter
- NEGATIVE IMPACT
Price Dip
In the last 6 months, SUNPHARMA stock has moved down by -6.0%
About Sun Pharmaceutical Industries Ltd
Sun Pharma's branded formulations include products for cardiovascular, central nervous system, gastroenterology, ophthalmology, and dermatology. Sun Pharma's specialty generics include injectables, inhalants, and complex products. Sun Pharma's API portfolio includes products for a range of therapeutic areas, including cardiovascular, central nervous system, gastroenterology, and dermatology.
Sun Pharma's top products include Modalert, a generic version of Modafinil for treating sleep disorders; Glocip, a generic version of Glipizide for treating diabetes; and Doxicip, a generic version of Doxycycline for treating bacterial infections. Sun Pharma's popular brands include Revital, a multivitamin supplement; Tazret, a topical retinoid for treating psoriasis; and Olmecip, a generic version of Olmesartan for treating hypertension.
Revenue: ₹13,786.07Cr as on June 2025 (Q1 FY26)
Net Profit: ₹2,302.62Cr as on June 2025 (Q1 FY26)
Listing date: 08 Feb, 1995
| Organisation | Sun Pharmaceutical Industries Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs
What is Sun Pharma share price today?
Sun Pharma share price today stands at ₹1607.1 as on . Sun Pharma share today touched a day high of ₹1610 and a low of ₹1600.
What is the 52 week high and 52 week low range for Sun Pharma share?
Sun Pharma touched a 52 week high of ₹1960.35 and a 52 week low of ₹1553.05. Sun Pharma share price today i.e. is trending at ₹1607.1, which is -18.02% down from its 52 week high and 3.48% up from its 52 week low.
What is Sun Pharma's market capitalisation today?
Sun Pharma market capitalisation is ₹3,84,373.46 Cr as on .
How to buy Sun Pharma shares?
To buy Sun Pharma shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for SUNPHARMA or Sun Pharmaceutical Industries Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Sun Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Sun Pharma trading volume today?
Sun Pharma trading volume is 10.48L as on . This means that 10.48L shares of Sun Pharma were bought and sold on the stock market during today's trading session.